A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and (68)Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial

BACKGROUND AND PURPOSE: The treatment of biochemical recurrence (BCR) after prostatectomy is challenging as the site of the recurrence is often undetectable. Our aim was to test a personalised treatment concept for BCR based on PSA kinetics during salvage radiotherapy (SRT) combined with prostate-sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunnlaugsson, Adalsteinn, Johannesson, Vilberg, Wieslander, Elinore, Brun, Eva, Bitzen, Ulrika, Ståhl, Olof, Bratt, Ola, Ahlgren, Göran, Ohlsson, Tomas, Kjellén, Elisabeth, Nilsson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305618/
https://www.ncbi.nlm.nih.gov/pubmed/35873652
http://dx.doi.org/10.1016/j.ctro.2022.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305618/
https://www.ncbi.nlm.nih.gov/pubmed/35873652
http://dx.doi.org/10.1016/j.ctro.2022.07.001

Ejemplares similares